VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 137 filers reported holding VERVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,295 | -29.6% | 20,158 | -0.5% | 0.00% | – |
| Q2 2023 | $379,857 | +19.3% | 20,259 | -8.3% | 0.00% | – |
| Q1 2023 | $318,408 | +1.2% | 22,081 | +35.8% | 0.00% | – |
| Q4 2022 | $314,593 | -94.5% | 16,258 | -90.2% | 0.00% | -100.0% |
| Q3 2022 | $5,674,000 | +2722.9% | 165,176 | +1159.1% | 0.00% | – |
| Q2 2022 | $201,000 | -11.1% | 13,119 | +32.5% | 0.00% | – |
| Q1 2022 | $226,000 | -16.0% | 9,899 | +35.7% | 0.00% | – |
| Q4 2021 | $269,000 | +8.5% | 7,293 | +38.4% | 0.00% | – |
| Q3 2021 | $248,000 | – | 5,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $661,184,000 | 13.47% |
| Casdin Capital, LLC | 3,038,167 | $183,050,000 | 4.65% |
| Logos Global Management LP | 758,265 | $45,685,000 | 3.84% |
| Novo Holdings A/S | 793,265 | $47,794,000 | 2.12% |
| Redmile Group, LLC | 1,936,530 | $116,676,000 | 1.73% |
| Cormorant Asset Management, LP | 709,224 | $40,594,000 | 1.38% |
| Rock Springs Capital Management LP | 962,826 | $58,011,000 | 1.15% |
| Asymmetry Capital Management, L.P. | 24,790 | $1,494,000 | 1.03% |
| Darwin Global Management, Ltd. | 103,013 | $6,207,000 | 1.00% |
| RA Capital Management | 880,284 | $53,037,000 | 0.85% |